Tuesday, May 24, 2016 3:22:36 PM
Get an idea of the market need for your product. Get your team and your funding together.
Get the individual pieces working correctly.
Make them efficient.
Make sure they're stable and will last.
We saw this with pursuing the voltage increases and the long term (1000 hours?) stability of the particles.
Get a system of these pieces together.
Make them efficient.
Make sure they're stable and will last.
We're seeing this now by looking to make dense sheets of these particles.
The next steps, not necessarily in this order, in my opinion:
- Look to keep the stability of these sheets up to par with that of the individual particles.
- Investigate the maintenance necessary to keep these sheets that way, if at all possible. How do we keep the the hydrogen produced from mixing with the oxygen with multiple sheets? Where does the waste go from the waste water? Can the sheet be made of smaller pieces that can be replaced individually?
- Build a commercial prototype, an MVP if you will, and use this to pursue and increase funding. <-- this is where I know we all want to be.
- Confirm the safety of the product. This will be a big issue with hydrogen.
- Build the functional, working, commercial product.
- Investigate the options for our end game. Licensing? Distribution? Installation? Maintenance? Do we build this for individual homes? Stations? Would the efficiency and safety allow it to be installed right into a car and we can sell them to dealers?
I have likely missed a number of other steps but the point is that there are a lot of things that can and/or need to be done. This is no quick business, it's a completely new field and it needs it's own due diligence.
-Justin
Recent HYSR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 09:31:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2024 05:15:09 AM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 01/25/2024 09:40:59 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/24/2024 09:32:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2023 09:03:04 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 08:33:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:13:34 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM